• Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes

  • Aug 5 2024
  • Length: 28 mins
  • Podcast

Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes

Listen for free

View show details

  • Summary

  • Riccardo De Giorgi joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that semaglutide may be associated with a reduced risk of a number of neurological and psychiatric outcomes, including cognitive deficits and dementia, as well as nicotine misuse.

    Read the full article:
    https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00305-5/fulltext?dgcid=buzzsprout_tlv_podcast_generic_eclinm

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show More Show Less
Physical Illness & Disease Hygiene & Healthy Living Biological Sciences
Show More Show Less
activate_samplebutton_t1

What listeners say about Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.